310 related articles for article (PubMed ID: 29441432)
1. Pediatric Intracranial Hypertension: a Current Literature Review.
Aylward SC; Way AL
Curr Pain Headache Rep; 2018 Feb; 22(2):14. PubMed ID: 29441432
[TBL] [Abstract][Full Text] [Related]
2. The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes.
Smith SV; Friedman DI
Headache; 2017 Sep; 57(8):1303-1310. PubMed ID: 28758206
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Intracranial Hypertension: A Spotlight on Imaging, the Idiopathic Intracranial Hypertension Treatment Trial, and COVID-19 Associated Cases.
Brun BN; Aylward SC
Semin Pediatr Neurol; 2021 Dec; 40():100922. PubMed ID: 34749916
[TBL] [Abstract][Full Text] [Related]
4. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.
;
Ophthalmology; 2015 Sep; 122(9):1939-45.e2. PubMed ID: 26198807
[TBL] [Abstract][Full Text] [Related]
5. Fulminant idiopathic intracranial hypertension managed with oral acetazolamide.
Espino Barros Palau A; Morgan ML; Yalamanchili S; Lee AG
Can J Ophthalmol; 2016 Aug; 51(4):e121-e125. PubMed ID: 27521679
[No Abstract] [Full Text] [Related]
6. Intracranial hypertension: a current review.
Jordan CO; Aylward SC
Curr Opin Pediatr; 2018 Dec; 30(6):764-774. PubMed ID: 30188410
[TBL] [Abstract][Full Text] [Related]
7. The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.
Sheils CR; Fischer WS; Hollar RA; Blanchard LM; Feldon SE;
Am J Ophthalmol; 2018 Nov; 195():101-109. PubMed ID: 30081012
[TBL] [Abstract][Full Text] [Related]
8. Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.
ten Hove MW; Friedman DI; Patel AD; Irrcher I; Wall M; McDermott MP;
J Neuroophthalmol; 2016 Mar; 36(1):13-9. PubMed ID: 26587993
[TBL] [Abstract][Full Text] [Related]
9. Should Acetazolamide Be the First-Line Treatment for Patients With Idiopathic Intracranial Hypertension?
Kaufman DI; Friedman DI
J Neuroophthalmol; 2017 Jun; 37(2):182-186. PubMed ID: 28376023
[No Abstract] [Full Text] [Related]
10. An update of idiopathic intracranial hypertension.
Madriz Peralta G; Cestari DM
Curr Opin Ophthalmol; 2018 Nov; 29(6):495-502. PubMed ID: 30169466
[TBL] [Abstract][Full Text] [Related]
11. Update on Idiopathic Intracranial Hypertension.
Wall M
Neurol Clin; 2017 Feb; 35(1):45-57. PubMed ID: 27886895
[TBL] [Abstract][Full Text] [Related]
12. Pseudotumor cerebri: yet another reason to fight obesity.
Stevenson SB
J Pediatr Health Care; 2008; 22(1):40-3. PubMed ID: 18174088
[TBL] [Abstract][Full Text] [Related]
13. The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait.
Beck RW
J Neuroophthalmol; 2016 Mar; 36(1):1-3. PubMed ID: 26882233
[No Abstract] [Full Text] [Related]
14. Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).
Wall M; Johnson CA; Cello KE; Zamba KD; McDermott MP; Keltner JL;
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):805-12. PubMed ID: 26934136
[TBL] [Abstract][Full Text] [Related]
15. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.
Wall M; Thurtell MJ;
Br J Ophthalmol; 2017 Sep; 101(9):1256-1260. PubMed ID: 28130349
[TBL] [Abstract][Full Text] [Related]
16. Pseudo-Foster Kennedy syndrome due to idiopathic intracranial hypertension.
Micieli JA; Al-Obthani M; Sundaram AN
Can J Ophthalmol; 2014 Aug; 49(4):e99-e102. PubMed ID: 25103671
[No Abstract] [Full Text] [Related]
17. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ
JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514
[TBL] [Abstract][Full Text] [Related]
18. Pediatric pseudotumor cerebri.
Rook BS; Phillips PH
Curr Opin Ophthalmol; 2016 Sep; 27(5):416-9. PubMed ID: 27491010
[TBL] [Abstract][Full Text] [Related]
19. The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6-12.
Wall M; Kupersmith MJ; Thurtell MJ; Moss HE; Moss EA; Auinger P;
Am J Ophthalmol; 2017 Apr; 176():102-107. PubMed ID: 28104417
[TBL] [Abstract][Full Text] [Related]
20. Pseudotumor cerebri.
Bandyopadhyay S
Arch Neurol; 2001 Oct; 58(10):1699-701. PubMed ID: 11594936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
